Temi della conferenza Cell therapies hold life-saving potential for patients and the race is on to develop best-in-class, living, 'thinking' drugs. Relapse rates and barriers to solid tumor efficacy mean the cell therapy industry must innovate, now more than ever.
Professional congress organizer (PCO) Hanson Wade
Annotazioni Speakers: Qi Cai Director of Cell Biology Kite Pharma, Tanja Obradovic Senior Scientific Director Takeda, Markus Vallaster Executive Medical Director AstraZeneca, Elena Peletskaya Director, Portfolio Technical Strategy Bristol Myers Squibb and more.
